p53 Ser 15 phosphorylation disrupts the p53-RPA70 complex and induces RPA70-mediated DNA repair in hypoxia

Biochemical Journal

Volumn 443, Issue 3, 2012, Pages 811-820

  Madan, Esha ^a   Gogna, Rajan ^a   Pati, Uttam ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

70 kDa subunit (RPA70); Gene therapy; Hypoxia; Non homologous end joining (NHEJ); Nucleotide excision repair (NER); p53; Replication protein A

Indexed keywords

PROTEIN KINASE; PROTEIN P53; REPLICATION FACTOR A; SERINE; THREONINE; RPA1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; DISSOCIATION; DNA END JOINING REPAIR; DNA REPAIR; EXCISION REPAIR; GENE MUTATION; GENE SILENCING; HYPOTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

CELL HYPOXIA; CELL LINE, TUMOR; DNA REPAIR; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; REPLICATION PROTEIN A; SERINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84860159919     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111627     Document Type: Article

References (51)

1. Zou, Y., Liu, Y., Wu, X. and Shell, S. M. (2006) Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J. Cell. Physiol. 208, 267-273
2. Fanning, E., Klimovich, V. and Nager, A. R. (2006) A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Res. 34, 4126-4137
3. Stauffer, M. E. and Chazin, W. J. (2004) Structural mechanisms of DNA replication, repair, and recombination. J. Biol. Chem. 279, 30915-30918
4. Costa, R. M., Chigancas, V., Galhardo Rda, S., Carvalho, H. and Menck, C. F. (2003) The eukaryotic nucleotide excision repair pathway. Biochimie 85, 1083-1099
5. Wold, M. S. (1997) Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66, 61-92
6. Bochkareva, E., Kaustov, L., Ayed, A., Yi, G. S., Lu, Y., Pineda-Lucena, A., Liao, J. C., Okorokov, A. L., Milner, J., Arrowsmith, C. H. and Bochkarev, A. (2005) Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc. Natl. Acad. Sci. U.S.A. 102, 15412-15417
7. Dutta, A., Ruppert, J. M., Aster, J. C. and Winchester, E. (1993) Inhibition of DNA replication factor RPA by p53. Nature 365, 79-82
8. Vogelstein, B., Lane, D. and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
9. Abramova, N. A., Russell, J., Botchan, M. and Li, R. (1997) Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 94, 7186-7191
10. Romanova, L. Y., Willers, H., Blagosklonny, M. V. and Powell, S. N. (2004) The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene 23, 9025-9033
11. Sommers, J. A., Sharma, S., Doherty, K. M., Karmakar, P., Yang, Q., Kenny, M. K., Harris, C. C. and Brosh, Jr, R. M. (2005) p53 modulates RPA-dependent and RPA-independent WRN helicase activity. Cancer Res. 65, 1223-1233
12. Albrechtsen, N., Dornreiter, I., Grosse, F., Kim, E., Wiesmuller, L. and Deppert, W. (1999) Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 18, 7706-7717
13. Janus, F., Albrechtsen, N., Dornreiter, I., Wiesmuller, L., Grosse, F. and Deppert, W. (1999) The dual role model for p53 in maintaining genomic integrity. Cell. Mol. Life Sci. 55, 12-27
14. Bindra, R. S., Schaffer, P. J., Meng, A., Woo, J., Maseide, K., Roth, M. E., Lizardi, P., Hedley, D. W., Bristow, R. G. and Glazer, P. M. (2005) Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability. Ann. N.Y. Acad. Sci. 1059, 184-195
15. Brown, L. M., Cowen, R. L., Debray, C., Eustace, A., Erler, J. T., Sheppard, F. C., Parker, C. A., Stratford, I. J. and Williams, K. J. (2006) Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1. Mol. Pharmacol. 69, 411-418
16. Bristow, R. G. and Hill, R. P. (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 8, 180-192
17. Huang, L. E., Bindra, R. S., Glazer, P. M. and Harris, A. L. (2007) Hypoxia-induced genetic instability-a calculated mechanism underlying tumor progression. J. Mol. Med. 85, 139-148
18. Bindra, R. S., Crosby, M. E. and Glazer, P. M. (2007) Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev. 26, 249-260
19. Rezvani, H. R., Mahfouf, W., Ali, N., Chemin, C., Ged, C., Kim, A. L., de Verneuil, H., Taieb, A., Bickers, D. R. and Mazurier, F. (2010) Hypoxia-inducible factor-1α regulates the expression of nucleotide excision repair proteins in keratinocytes. Nucleic Acids Res. 38, 797-809
20. Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M. and Wenger, R. H. (2003) The hypoxia-inducible factor-1α is a negative factor for tumor therapy. Oncogene 22, 3213-3220
21. Murray, D., Vallee-Lucic, L., Rosenberg, E. and Andersson, B. (2002) Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide. Anticancer Res. 22, 21-26
22. Mao, Z., Seluanov, A., Jiang, Y. and Gorbunova, V. (2007) TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination. Proc. Natl. Acad. Sci. U.S.A. 104, 13068-13073
23. Biggerstaff, M. and Wood, R. D. (2006) Repair synthesis assay for nucleotide excision repair activity using fractionated cell extracts and UV-damaged plasmid DNA. Methods Mol. Biol. 314, 417-434
24. Li, G. and Ho, V. C. (1998) p53-dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation. Br. J. Dermatol. 139, 3-10
25. Sullivan, R., Pare, G. C., Frederiksen, L. J., Semenza, G. L. and Graham, C. H. (2008) Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity. Mol. Cancer Ther. 7, 1961-1973
26. Fyles, A. W., Milosevic, M., Wong, R., Kavanagh, M. C., Pintilie, M., Sun, A., Chapman, W., Levin, W., Manchul, L., Keane, T. J. and Hill, R. P. (1998) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 48, 149-156
27. Sasabe, E., Zhou, X., Li, D., Oku, N., Yamamoto, T. and Osaki, T. (2007) The involvement of hypoxia-inducible factor-1α in the susceptibility to γ-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells. Int. J. Cancer 120, 268-277
28. Wood, R. D. (1996) DNA repair in eukaryotes. Annu. Rev. Biochem. 65, 135-167
29. Gogna, R., Madan, E., Kuppusamy, P. and Pati, U. (2012) Chaperoning of mutant p53 by wild-type p53 causes hypoxic tumor regression. J. Biol. Chem. 287, 2907-2914
30. Ward, I. M., Minn, K. and Chen, J. (2004) UV-induced ataxia- telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress. J. Biol. Chem. 279, 9677-9680
31. Yajima, H., Lee, K. J., Zhang, S., Kobayashi, J. and Chen, B. P. (2009) DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases. J. Mol. Biol. 385, 800-810
32. Bhana, S., Hewer, A., Phillips, D. H. and Lloyd, D. R. (2008) p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells. Mutagenesis 23, 131-136
33. Jones, J. C., Zhen, W. P., Reed, E., Parker, R. J., Sancar, A. and Bohr, V. A. (1991) Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J. Biol. Chem. 266, 7101-7107
34. Saijo, M., Matsuda, T., Kuraoka, I. and Tanaka, K. (2004) Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH. Biochem. Biophys. Res. Commun. 321, 815-822
35. Zhong, Q., Boyer, T. G., Chen, P. L. and Lee, W. H. (2002) Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res. 62, 3966-3970
36. Ginis, I. and Faller, D. V. (2000) Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). Cancer Lett. 154, 163-174
37. Lynch, E. M., Moreland, R. B., Ginis, I., Perrine, S. P. and Faller, D. V. (2001) Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am. J. Physiol. Cell Physiol. 280, C897-C911
38. Bindra, R. S., Gibson, S. L., Meng, A., Westermark, U., Jasin, M., Pierce, A. J., Bristow, R. G., Classon, M. K. and Glazer, P. M. (2005) Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res. 65, 11597-11604
39. Perrault, R., Cheong, N., Wang, H. and Iliakis, G. (2001) RPA facilitates rejoining of DNA double-strand breaks in an in vitro assay utilizing genomic DNA as substrate. Int. J. Radiat. Biol. 77, 593-607
40. Sharma, A. K., Ali, A., Gogna, R., Singh, A. K. and Pati, U. (2009) p53 amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype. PLoS ONE 4, e7159
41. Thompson, T., Tovar, C., Yang, H., Carvajal, D., Vu, B. T., Xu, Q., Wahl, G. M., Heimbrook, D. C. and Vassilev, L. T. (2004) Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol. Chem. 279, 53015-53022
42. Ashcroft, M., Kubbutat, M. H. and Vousden, K. H. (1999) Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 19, 1751-1758
43. Unger, T., Sionov, R. V., Moallem, E., Yee, C. L., Howley, P. M., Oren, M. and Haupt, Y. (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18, 3205-3212
44. Soubeyrand, S., Schild-Poulter, C. and Hache, R. J. (2004) Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18. Eur. J. Biochem. 271, 3776-3784
45. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E. and Anderson, C. W. (1992) Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041-5049
46. Derheimer, F. A., O'Hagan, H. M., Krueger, H. M., Hanasoge, S., Paulsen, M. T. and Ljungman, M. (2007) RPA and ATR link transcriptional stress to p53. Proc. Natl. Acad. Sci. U.S.A. 104, 12778-12783
47. Esashi, F., Christ, N., Gannon, J., Liu, Y., Hunt, T., Jasin, M. and West, S. C. (2005) CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434, 598-604
48. Hammond, E. M., Dorie, M. J. and Giaccia, A. J. (2003) ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 278, 12207-12213
49. Shiloh, Y. (2003) ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3, 155-168
50. Yee Koh, M., Spivak-Kroizman, T. R. and Powis, G. (2008) HIF-1 regulation: not so easy come, easy go. Trends Biochem. Sci. 33, 526-534
51. Um, J. H., Kang, C. D., Bae, J. H., Shin, G. G., Kim, D. W., Chung, B. S. and Kim, S. H. (2004) Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells. Exp. Mol. Med. 36, 233-242